A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors
Clinical trial NCT01171924 · COMPLETED
Trial details
- NCT number
- NCT01171924
- Sponsor
- Curis, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-10-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.